Introduction
Primary biliary cholangitis (PBC) is a chronic progressive cholestatic liver disease. Portal hypertension (PH) is a common complication of chronic progressive liver disease that can occur early in the course of PBC [
1]. Although a mechanism has not been elucidated, several hypotheses for PH pathogenesis have been proposed, including granulomatous inflammation compressing the branches of the portal vein, leading to pre-sinusoidal PH, pre-sinusoidal fibrosis, and nodular regenerative hyperplasia [
2]. PBC has an insidious onset but rapid progression. Variceal rupture and hemorrhage are among the most concerning complications of cirrhosis. The 3-year survival rate after variceal rupture and hemorrhage in patients with PBC is only 46% [
3]; therefore, screening for PH to prevent gastrointestinal bleeding is of great clinical importance in these patients.
Esophagogastroduodenoscopy (EGD) can be used to identify patients at risk of variceal rupture, yet the prevalence of varices in patients with compensated cirrhosis is only 5–15% in actual clinical practice [
4]. A major problem is avoiding unnecessary endoscopic screening and non-invasively predicting the risk of variceal rupture due to PH. Transient elastography (TE) is a non-invasive technique that can be used to accurately determine liver fibrosis by measuring liver stiffness. Growing evidence suggests that TE can reflect the hepatic venous pressure gradient (HVPG) for PH assessment [
5]. The guidelines of the Baveno VII Consensus Workshop recommended that EGD screening could be performed in patients with compensated cirrhosis, liver stiffness measurement (LSM) ≥ 20 kPa, or platelet count ≤ 150 × 10
9/L [
6]. Studies have also questioned the value of TE in predicting clinically significant PH (CSPH), suggesting that it is not sufficiently accurate to replace HVPG [
7,
8]. The spleen enlarges with disease progression in most patients with PBC, with characteristic features on ultrasound [
9]. Thus, the present study investigated the effectiveness of TE and ultrasound imaging in predicting PBC in patients with esophageal or fundic varices.
Discussion
Screening for varices in patients with PBC and PH can effectively reduce the morbidity and mortality of gastrointestinal hemorrhage. However, the prediction of rupture or hemorrhage from esophageal and fundic varices remains challenging. Current research is focused on the use of non-invasive tests to replace HVPG measurement and reduce unnecessary endoscopic screening. In the present study, we used multiple non-invasive methods to predict varices needing treatment while investigating the applicability of the Baveno VII consensus guidelines to patients with PBC, aiming to complement non-invasive predictive tools for PH.
PH with HVPG ≥ 10 mmHg is associated with the development of esophageal varices and poor prognosis [
8]. HVPG measurement is currently recommended in international studies as a diagnostic indicator for the accurate determination of CSPH [
11]. However, HVPG is a moderately invasive procedure and most patients with chronic liver disease require long-term follow-up. TE is a common non-invasive clinical examination that plays an important role in the determination of CSPH. Previous findings suggest that the risk of CSPH may be very low (< 9%) for LSM < 13.6 kPa [
12]. A meta-analysis by the American Gastroenterological Association Institute using a range of LSM cutoffs (14.6–47.2 kPa) reported in 15 studies for the detection of high-risk EV indicated that the recommended cutoff of ≤ 19.5 (±2) kPa may misclassify 0.6% patients as not having high-risk EVs and 41.8% patients as having high-risk EVs due to the wide range of cutoffs [
13]. Augustin et al concluded that CSPH can be accurately determined using an LSM cutoff of > 25 kPa and that the positive predictive power is slightly reduced with an LSM cutoff of > 21.1 kPa, although this reduced the proportion of patients in the LSM gray area [
14]. In the present study, predicting esophageal or fundic varices using an LSM cutoff of > 12.1 kPa allowed endoscopic screening to be avoided in 77% of patients, with a false-negative rate of 20.3% and a false-positive rate of 29.7%.
Based on the Baveno VII guidelines, endoscopic screening can be avoided for a subset of patients who have undergone follow-up with repeated TE examinations and PLT, whereas patients with LSM ≥ 20 kPa or PLT ≤ 150 × 10
9/L should undergo endoscopy for varices screening [
6]. However, only using a diagnostic threshold of LSM ≥ 20 kPa, the diagnostic accuracy in the present cohort of patients with PBC was lower compared with a diagnostic threshold of LSM > 12.1 kPa, and the rate of misdiagnosis increased by 5.4%. LSM ≥ 21 kPa has been used as a threshold for the clinical prediction of CSPH in hepatitis C [
15]. The diagnostic threshold for alcoholic cirrhosis is higher than that for viral cirrhosis (34.9 kPa vs. 20.5 kPa) [
12]. Thus, the LSM threshold for patients with PBC is lower than those for other chronic liver diseases, demonstrating that PH is already present in the early stages of PBC, consistent with the findings reported by Murata et al One possible mechanism for PH development in the early stages of PBC is related to granulomatous inflammation compressing the branches of the portal vein, leading to pre-sinusoidal PH, pre-sinusoidal fibrosis, and nodular regenerative hyperplasia [
16]. These results indicated that when LSM was the only reference value, the diagnostic accuracy for varicose veins with LSM ≥ 20 kPa was slightly lower than that in our study. Instead, we recommend that LSM > 12.1 kPa may be a manifestation of PH and suggest that patients with PBC undergo endoscopy to screen for varices. Although recommended as a non-invasive means of reducing endoscopic screening, vibration-controlled TE is not intended as an alternative to EGD [
13].
The umbilical vein is the most specific sign of PH on ultrasound, with a characteristic sign being the appearance of dilated veins in the falciform ligament [
17]. Similarly, ascites and portosystemic collaterals are ultrasound manifestations suggestive of PH. However, not all patients with PH present with these manifestations; in the present study, 38.2% of patients (42/110, with one patient who underwent splenectomy and one patient who underwent splenoembolization) presenting with varices did not present with ultrasound manifestations. The periportal halo or PHB is a characteristic imaging feature in patients with progressive PBC and is believed to be associated with periportal fibrosis or inflammatory cell infiltration. In PBC, the PHB gradually widens with disease progression [
9]. In the present study, the incidence of varices was significantly increased when PHB was present, and PLT was significantly lower than in patients without PHB. The incidence rates of esophageal varices and fundic varices were 84.1% and 44.4%, respectively, in the PHB group and 40.8% and 14.3%, respectively, in the non-PHB group. The incidence of PHB was higher in the PH rupture and hemorrhage group than in the non-hemorrhage group, suggesting that the presence of PHB is predictive of disease progression in patients with PBC. In addition, splenomegaly is the most common feature of CSPH [
18]. The splenic area plays a role in the prediction of esophageal or fundic varices and the risk of variceal rupture and hemorrhage, with a predictive power not inferior to that of LSM. This is primarily due to its simplicity of calculation, the lack of constraints, and its objective nature. Thus, the measurement of splenic area may be a promising alternative at institutions where TE is not available. We recommend the risk stratification of patients with PBC based on splenic area. In patients with splenic area ≤ 41.2 cm
2, regular follow-up is recommended, and endoscopic screening is not needed. When the splenic area is 41.2–56.8 cm
2, varices are likely present, and endoscopic screening is highly recommended. Finally, when the splenic area is > 56.8 cm
2, the risk of variceal rupture and hemorrhage is high, and clinicians should implement appropriate measures to prevent gastrointestinal hemorrhage.
This study has several limitations. First, due to partially missing data, an insufficient number of retrospective cases were included for analysis. Second, due to the retrospective nature of the study, only subjective judgment could be made on PHB using static ultrasound images, which cannot fully reflect the prediction of PHB for varicose veins risk. In a future study, we will further standardize the storage of PHB images, increase the storage of dynamic images, and record the existence of PHB ultrasonic findings. In addition, our analysis of PHB should not only be limited to the analysis of images, it should have further increased the quantitative measurement. Finally, we did not analyze the long-term survival of patients with PBC evaluated with the two techniques; this assessment will be the focus of future studies.
In conclusion, the results of the present study suggested LSM > 12.1 kPa as a risk threshold value for predicting the presence of esophageal or fundic varices in patients with PBC. The splenic area showed high accuracy and relevance for predicting varicose veins and variceal rupture and can be used for prediction at thresholds of > 41.2 cm2 and > 56.8 cm2 respectively. LSM and splenic area measurements are simple and highly reproducible and can allow endoscopy to be safely avoided.
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.